PhoenixDx® SARS-CoV-2 Multiplex RUO (FDA EUA)

Price on request at

sales@procomcure.com

PHOENIXDX® SARS-COV-2 MULTIPLEX RUO (FDA EUA) is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection of 2019-Novel Coronavirus (SARS-CoV-2) in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

PHOENIXDX® SARS-COV-2 MULTIPLEX RUO (FDA EUA) is not affected by the novel UK mutant of SARS-CoV-2.

Artikelnummer: PCCSKU15262 Kategorien: , Schlagwörter: ,

Beschreibung

PHOENIXDX® SARS-COV-2 MULTIPLEX IVD detects the presence of 2 different and highly specific gene sequences of corona viruses and one sequence specific for human RNA serving as a human extraction control (HEC). Additionally, a non-infectious target positive control (TPC) is included. The positive control is used to confirm functionality of the assays and overall PCR performance, the human extraction control is to evaluate the quality of the RNA isolation independently from the SARS-CoV-2 assays in a different detection channel.

Download the FDA EUA here

Download MSDS here

Download IFU here